AIM To evaluate the effect of abdominal radical trachelectomy on ovarian reserve and compare it with abdominal radical hysterectomy and a control group that did not have surgery. METHOD We enrolled eighteen women who had abdominal radical trachelectomy with pelvic lymphadenectomy and sixteen patients who had abdominal radical hysterectomy for this study. Ten thousand one hundred eighty-six wo...

Aim To assess ovarian reserve (OVR) by means of follicle-stimulating hormone (FSH), anti-Müllerian hormone (AMH), and antral follicle count (AFC) measurement in eumenorrheic women with breast cancer, exposed to gonadotoxic chemotherapy. Method Fifty-two women (35.3 ± 3.8 years old) with breast cancer and undergoing cyclophosphamide-containing chemotherapy were enrolled. The assessment was perfo...

OBJECTIVE To evaluate serum anti-Müllerian hormone (AMH) in well-characterized men with normal and reduced sperm concentration and in men with a history of or persistent maldescended testes as a possible clinical marker of male factor infertility and/or maldescended testes. DESIGN Retrospective analysis of 199 men selected from our database (Androbase). SETTING The university-based Institut...

Background: Polycystic ovary syndrome (PCOS) is one of the main factors leading to infertility and ovulatory dysfunction in women. The aim current research study levels Inhibin A B women with PCOS, depending on level Anti-millerian hormone. Materials methods: 30 infertile (I group) PCOS (excluding hyperprolactenemia, hypothyreosis, autoimmune thyroiditis) healthy (II were involved study. Hormon...

The authors measured plasma anti-Müllerian hormone (AMH) levels over 2x 5-year intervals in a prospective cohort study of 3293 healthy women aged 20–59 years at baseline. Lower baseline age-specific AMH were associated with higher risk Type 2 diabetes (T2D) after median 20 follow-up. When trajectories predicted each individual, lower younger ages seen who subsequently developed T2D.

Objectives. The aim of our study was to examine serum anti-Müllerian hormone (AMH) concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, (FIGO) stage, grading, and overall 5-year survival. Material and Methods. We enrolled 72 epithelial ovarian cancer patients in our study, aged 45-79 years, who underwent optimal cytor...